MYX-2470

N/A

Report date: 2026/04/22 20:01:10

First In Class

Base Information

Drug NameMYX-2470

Drug Alias NameMYX2470MYX-2470

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionPeptide N-myristoyltransferase 1 inhibitorsPeptide N-myristoyltransferase 2 inhibitorsAnti-CD276

TargetsPeptide N-myristoyltransferase 1Peptide N-myristoyltransferase 2CD276 antigen

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMyricx Pharma Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A